Income Statement GC Corp.

Stocks

A005250

KR7005250006

Pharmaceuticals

End-of-day quote Korea S.E. 2026-09-03			5-day change	1st Jan Change
9,850.00 ^KRW	0.00%		-4.46%	-38.13%

08-14	GC Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
06-10	GC Corp.(KOSE:A005250) dropped from KOSPI 200 Index	CI

1fdf6df9ce8aa666df5ece13576112._aB9MaMz3Z43V0kVrNWQTxHjaXNG-ncRoq4nmo_LeMs.iOQ6BsBWgqt_bid62ZrIAlmFPQQZuEVfwdh4-O78E4qe9gxQm32lzQUbKg

Published financial data: GC CORP.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (KRW)	2022 (KRW)	2023 (KRW)	2024 (KRW)	2025 (KRW)
Revenues	1,834B	2,072B	2,058B	2,205B	2,451B
Interest And Invest. Income (Rev)	6.33B	7.61B	-	-	-
Other Revenues, Total	-340	-330	-10	-	-
Total Revenues	1,841B	2,080B	2,058B	2,205B	2,451B
Cost of Goods Sold, Total	1,214B	1,384B	1,456B	1,587B	1,771B
Gross Profit	627B	696B	602B	618B	681B
Selling General & Admin Expenses, Total	369B	406B	410B	426B	456B
Provision for Bad Debts	7.39B	3.58B	9.17B	3.09B	5.76B
R&D Expenses	147B	194B	179B	175B	157B
Depreciation & Amortization - (IS)	6.93B	9.17B	10.05B	9.83B	8.34B
Amortization of Goodwill and Intangible Assets - (IS)	5.06B	7.07B	8.49B	10.34B	14.81B
Other Operating Expenses	5.16B	6.33B	5.86B	4.86B	3.28B
Other Operating Expenses, Total	541B	626B	623B	629B	646B
Operating Income	86B	70.22B	-21.83B	-10.99B	34.99B
Interest Expense, Total	-27.52B	-36.48B	-53.1B	-66.57B	-72B
Interest And Investment Income	3.1B	5.62B	6.51B	7B	5.54B
Net Interest Expenses	-24.42B	-30.85B	-46.59B	-59.57B	-66.47B
Income (Loss) On Equity Invest.	-	39.43B	-	189B	61.5B
Currency Exchange Gains (Loss)	20.82B	870M	223M	5.27B	-2.17B
Other Non Operating Income (Expenses)	2.37B	-24.75M	9.55B	-10.12B	-7.46B
EBT, Excl. Unusual Items	84.77B	79.64B	-58.65B	113B	20.4B
Gain (Loss) On Sale Of Investments	86.26B	-52.19B	-32.49B	-33.28B	44.38B
Gain (Loss) On Sale Of Assets	11.82B	2.18B	10.03B	-4.64B	-1.94B
Asset Writedown	-2.84B	-	-	-32.24B	-116B
Other Unusual Items	-	-	-	-738M	-148M
EBT, Incl. Unusual Items	180B	29.63B	-81.11B	42.52B	-53.44B
Income Tax Expense	52.36B	-29.27B	-9.47B	53.61B	-11.62B
Earnings From Continuing Operations	128B	58.9B	-71.64B	-11.09B	-41.82B
Earnings Of Discontinued Operations	-	-	-1.15B	-	-
Net Income to Company	128B	58.9B	-72.79B	-11.09B	-41.82B
Minority Interest	-72.39B	-26.07B	18.66B	35.11B	-27.69B
Net Income - (IS)	55.27B	32.82B	-54.14B	24.03B	-69.51B
Preferred Dividend and Other Adjustments	737M	333M	466M	497M	-715M
Net Income to Common Incl Extra Items	54.53B	32.49B	-54.6B	23.53B	-68.8B
Net Income to Common Excl. Extra Items	54.53B	32.49B	-53.45B	23.53B	-68.8B
Per Share Items
Net EPS - Basic	1.2K	715.6	-1.2K	518.22	-1.53K
Basic EPS - Continuing Operations	1.2K	715.6	-1.18K	518.22	-1.53K
Basic Weighted Average Shares Outstanding	45.4M	45.4M	45.4M	45.4M	44.93M
Net EPS - Diluted	1.2K	715.6	-1.2K	518.22	-1.53K
Diluted EPS - Continuing Operations	1.2K	715.6	-1.18K	518.22	-1.53K
Diluted Weighted Average Shares Outstanding	45.4M	45.4M	45.4M	45.4M	44.93M
Normalized Basic EPS	-427.42	522.02	-396.45	2.33K	-332.53
Normalized Diluted EPS	-427.42	522.02	-396.45	2.33K	-332.53
Dividend Per Share	400	300	300	500	-
Payout Ratio	58.33	95.97	-55.29	105.86	-47.77
Supplemental Items
EBITDA	148B	149B	73.02B	92.75B	142B
EBITA	94.86B	82.76B	-6.93B	9.81B	61.02B
EBIT	86B	70.22B	-21.83B	-10.99B	34.99B
EBITDAR	154B	154B	80.08B	100B	151B
Effective Tax Rate - (Ratio)	29.08	-98.78	11.68	126.08	21.75
Normalized Net Income	-19.41B	23.7B	-18B	106B	-14.94B
Supplemental Operating Expense Items
Advertising Expense	50.2B	51.58B	42.58B	37.13B	46.28B
Marketing Expenses	1.26B	1.71B	1.31B	996M	995M
Selling and Marketing Expenses	161B	162B	147B	146B	177B
Research And Development Expense From Footnotes	147B	194B	179B	175B	157B
Net Rental Expense, Total	5.61B	5.48B	7.06B	7.49B	8.89B
Imputed Operating Lease Interest Expense	1.16B	1.49B	2.52B	3.32B	3.91B
Imputed Operating Lease Depreciation	4.45B	3.99B	4.54B	4.18B	4.98B
Maintenance & Repair Expenses, Total	1.64B	2.32B	1.92B	2.09B	2.05B

Fiscal Period: December	2021 (KRW)	2022 (KRW)	2023 (KRW)	2024 (KRW)	2025 (KRW)
Assets
Cash And Equivalents	336B	209B	175B	77.3B	79.66B
Short Term Investments	-680	-300	-340	-50	-160
Trading Asset Securities, Total	62.83B	31.34B	21.57B	6.79B	19.63B
Total Cash And Short Term Investments	398B	240B	196B	84.1B	99.28B
Accounts Receivable, Total	475B	453B	517B	454B	481B
Other Receivables	17.8B	24.13B	24.08B	17.6B	12.38B
Notes Receivable	1.06B	2.02B	2.51B	10.93B	5.26B
Total Receivables	494B	479B	544B	482B	499B
Inventory	507B	505B	580B	761B	910B
Prepaid Expenses	7.68B	9.79B	8.95B	14.73B	20.72B
Other Current Assets, Total	12.29B	27.44B	32.49B	37.42B	18.54B
Total Current Assets	1,419B	1,262B	1,361B	1,379B	1,547B
Gross Property Plant And Equipment	1,462B	1,566B	1,590B	1,541B	1,693B
Accumulated Depreciation	-373B	-418B	-473B	-513B	-557B
Net Property Plant And Equipment	1,089B	1,148B	1,117B	1,029B	1,136B
Long-term Investments	310B	368B	344B	374B	402B
Goodwill	362B	454B	458B	443B	460B
Other Intangibles, Total	93.17B	119B	127B	111B	169B
Accounts Receivable Long-Term	5.39B	4.95B	3.8B	2.04B	13.5B
Loans Receivable Long-Term	1.58B	5.93B	3.98B	1.76B	3.05B
Deferred Tax Assets Long-Term	22.05B	32.14B	40.83B	56.41B	74.44B
Deferred Charges Long-Term	77.69B	92.35B	109B	110B	95B
Other Long-Term Assets, Total	116B	105B	172B	165B	169B
Total Assets	3,497B	3,592B	3,738B	3,671B	4,069B
Liabilities
Accounts Payable, Total	141B	144B	167B	176B	211B
Accrued Expenses, Total	109B	127B	95.75B	101B	147B
Short-term Borrowings	366B	451B	600B	471B	512B
Current Portion of Long-Term Debt	143B	152B	412B	207B	381B
Current Portion of Leases	6.35B	11.65B	16.21B	15.45B	17.38B
Current Income Taxes Payable	44.39B	19.12B	6.61B	60.04B	14.1B
Unearned Revenue Current, Total	15.26B	15.23B	29B	24.51B	14.4B
Other Current Liabilities	100B	133B	186B	217B	312B
Total Current Liabilities	926B	1,052B	1,513B	1,273B	1,608B
Long-Term Debt	509B	448B	216B	411B	476B
Long-Term Leases	21.22B	34.85B	35.3B	20.81B	108B
Unearned Revenue Non Current	16.3B	14.05B	7.5B	7.4B	5.17B
Pension & Other Post Retirement Benefits	1.86B	3.38B	4.98B	26.35B	51.53B
Deferred Tax Liability Non Current	85.92B	34.63B	28.5B	30.15B	20.27B
Other Non Current Liabilities	26.11B	37.4B	50.32B	49.15B	36.6B
Total Liabilities	1,586B	1,625B	1,856B	1,818B	2,305B
Common Stock, Total	26.58B	26.58B	26.58B	26.58B	26.58B
Additional Paid In Capital	60.29B	51.07B	56.14B	68.1B	73.82B
Retained Earnings	945B	959B	897B	897B	807B
Treasury Stock	-18.29B	-18.29B	-18.29B	-18.29B	-18.15B
Comprehensive Income and Other	11.69B	19.23B	19.31B	20.88B	11.89B
Total Common Equity	1,025B	1,038B	980B	994B	901B
Minority Interest	885B	929B	901B	858B	863B
Total Equity	1,911B	1,967B	1,882B	1,852B	1,764B
Total Liabilities And Equity	3,497B	3,592B	3,738B	3,671B	4,069B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	45.63M	45.4M	45.4M	45.4M	44.97M
ECS Total Common Shares Outstanding	45.63M	45.4M	45.4M	45.4M	44.97M
Book Value / Share	22.47K	22.86K	21.59K	21.9K	20.03K
Tangible Book Value	570B	464B	396B	440B	272B
Tangible Book Value Per Share	12.49K	10.22K	8.72K	9.69K	6.05K
Total Debt	1,046B	1,098B	1,280B	1,126B	1,493B
Net Debt	647B	858B	1,084B	1,042B	1,394B
Debt Equivalent Oper. Leases	44.87B	43.83B	56.48B	59.93B	71.1B
Minority Interest, Total (Incl. Fin. Div)	885B	929B	901B	858B	863B
Equity Method Investments, Total	164B	242B	214B	182B	201B
Inventories - Raw Materials, Total	127B	129B	157B	158B	242B
Inventories - Work In Process, Total	201B	226B	220B	293B	334B
Inventories - Finished Goods, Total	210B	192B	240B	343B	367B
Inventories - Others	50	130	-40	450	-40
Land - (BS)	203B	204B	163B	153B	143B
Buildings, Total	657B	722B	778B	759B	777B
Machinery, Total	363B	413B	449B	448B	478B
Accumulated Allowance for Doubtful Accounts (Supple)	12.55B	15.1B	11.74B	12.74B	17.14B

Fiscal Period: December	2021 (KRW)	2022 (KRW)	2023 (KRW)	2024 (KRW)	2025 (KRW)
Net Income	55.27B	32.82B	-54.14B	24.03B	-69.51B
Depreciation & Amortization - CF	53.59B	66.12B	79.95B	82.95B	81.14B
Amortization of Goodwill and Intangible Assets - (CF)	8.86B	12.54B	14.9B	20.79B	26.03B
Depreciation & Amortization, Total	62.44B	78.66B	94.85B	104B	107B
(Gain) Loss From Sale Of Asset	-11.82B	-41.6B	-10.03B	-184B	-59.56B
(Gain) Loss on Sale of Investments - (CF)	-18.14B	17.51B	-13.16B	1.65B	-25.2B
Asset Writedown & Restructuring Costs	2.84B	-	-	32.24B	116B
(Income) Loss On Equity Investments - (CF)	-68.12B	34.67B	45.65B	31.64B	-19.18B
Stock-Based Compensation (CF)	-	500M	-	-	-
Provision and Write-off of Bad Debts	7.14B	2.64B	3.78B	2.82B	4.29B
Other Operating Activities, Total	103B	-15.73B	-15.18B	33.21B	-12.16B
Change In Accounts Receivable	-40.41B	20.51B	-67.36B	55.8B	-38.12B
Change In Inventories	-8.95B	-2.81B	-70.92B	-230B	-129B
Change In Accounts Payable	-18.11B	657M	23.57B	10.03B	33.52B
Change in Unearned Revenues	3.62B	7.7B	12.14B	-6.23B	-9.58B
Change in Other Net Operating Assets	35.07B	-38.37B	11.15B	35.3B	125B
Cash from Operations	104B	97.16B	-39.65B	-89.95B	24.3B
Capital Expenditure	-117B	-73.22B	-89.96B	-43.89B	-111B
Sale of Property, Plant, and Equipment	4.31B	18.85B	3.65B	1.08B	3.58B
Cash Acquisitions	4.96B	-177B	-2.18B	251B	-61.17B
Divestitures	92.63M	-	-	-	-
Sale (Purchase) of Intangible assets	-27.66B	-52.52B	-41.62B	-12.93B	-34.51B
Investment in Marketable and Equity Securities, Total	-42.41B	2.45B	-4.24B	-48.41B	-51.48B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	-178M
Other Investing Activities, Total	67.1B	-2.95B	20	380	10
Cash from Investing	-110B	-284B	-134B	147B	-255B
Short Term Debt Issued, Total	1,101B	1,230B	1,627B	1,709B	1,717B
Long-Term Debt Issued, Total	337B	87.52B	14.86B	280B	421B
Total Debt Issued	1,439B	1,318B	1,642B	1,989B	2,138B
Short Term Debt Repaid, Total	-1,313B	-1,143B	-1,482B	-1,827B	-1,685B
Long-Term Debt Repaid, Total	-184B	-134B	-32.81B	-273B	-95.18B
Total Debt Repaid	-1,496B	-1,277B	-1,515B	-2,101B	-1,781B
Issuance of Common Stock	-	-	37.09B	12.13B	536M
Repurchase of Common Stock	-	-	-	-	-
Common Dividends Paid	-32.24B	-31.5B	-29.93B	-25.43B	-33.21B
Common & Preferred Stock Dividends Paid	-32.24B	-31.5B	-29.93B	-25.43B	-33.21B
Other Financing Activities, Total	-26.27B	42.21B	6.36B	-15.96B	-96.28B
Cash from Financing	-116B	51.34B	141B	-141B	228B
Foreign Exchange Rate Adjustments	10.89B	8.54B	-657M	-13.1B	4.51B
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	-112B	-127B	-34.1B	-97.23B	2.35B
Supplemental Items
Cash Interest Paid	28.84B	34.19B	47.49B	66.59B	71.37B
Cash Income Tax Paid (Refund)	35.35B	56.52B	23.54B	5.26B	58.85B
Levered Free Cash Flow	-36.03B	667M	-180B	-37.2B	-94.34B
Unlevered Free Cash Flow	-18.83B	23.46B	-147B	4.41B	-49.34B
Change In Net Working Capital	-9.23B	-26.66B	96.43B	35.65B	32.97B
Net Debt Issued / Repaid	-57.95B	40.63B	127B	-112B	357B

Fiscal Period: December	2021 (KRW)	2022 (KRW)	2023 (KRW)	2024 (KRW)	2025 (KRW)
Profitability
Return on Assets	1.6	1.24	-0.37	-0.19	0.57
Return on Total Capital	1.88	1.46	-0.44	-0.22	0.7
Return On Equity %	7.12	3.04	-3.72	-0.59	-2.31
Return on Common Equity	5.61	3.15	-5.3	2.38	-7.26
Margin Analysis
Gross Profit Margin %	34.06	33.47	29.24	28.04	27.77
SG&A Margin	20.05	19.51	19.95	19.34	18.61
EBITDA Margin %	8.06	7.16	3.55	4.21	5.8
EBITA Margin %	5.15	3.98	-0.34	0.44	2.49
EBIT Margin %	4.67	3.38	-1.06	-0.5	1.43
Income From Continuing Operations Margin %	6.94	2.83	-3.48	-0.5	-1.71
Net Income Margin %	3	1.58	-2.63	1.09	-2.84
Net Avail. For Common Margin %	2.96	1.56	-2.6	1.07	-2.81
Normalized Net Income Margin	-1.05	1.14	-0.87	4.81	-0.61
Levered Free Cash Flow Margin	-1.96	0.03	-8.75	-1.69	-3.85
Unlevered Free Cash Flow Margin	-1.02	1.13	-7.13	0.2	-2.01
Asset Turnover
Asset Turnover	0.55	0.59	0.56	0.6	0.63
Fixed Assets Turnover	1.77	1.86	1.82	2.06	2.26
Receivables Turnover (Average Receivables)	4.04	4.46	4.24	4.54	5.25
Inventory Turnover (Average Inventory)	2.44	2.73	2.68	2.37	2.12
Short Term Liquidity
Current Ratio	1.53	1.2	0.9	1.08	0.96
Quick Ratio	0.96	0.68	0.49	0.44	0.37
Operating Cash Flow to Current Liabilities	0.11	0.09	-0.03	-0.07	0.02
Days Sales Outstanding (Average Receivables)	90.34	81.76	86.07	80.61	69.58
Days Outstanding Inventory (Average Inventory)	149.79	133.5	135.95	154.62	172.18
Average Days Payable Outstanding	44.37	37.71	37.13	35.57	36.8
Cash Conversion Cycle (Average Days)	195.76	177.55	184.89	199.66	204.96
Long Term Solvency
Total Debt/Equity	54.73	55.81	68.04	60.8	84.66
Total Debt / Total Capital	35.37	35.82	40.49	37.81	45.85
LT Debt/Equity	27.74	24.57	13.37	23.32	33.1
Long-Term Debt / Total Capital	17.93	15.77	7.96	14.5	17.92
Total Liabilities / Total Assets	45.36	45.24	49.66	49.54	56.66
EBIT / Interest Expense	3.12	1.93	-0.41	-0.17	0.49
EBITDA / Interest Expense	5.39	4.08	1.37	1.39	1.97
(EBITDA - Capex) / Interest Expense	1.16	2.07	-0.32	0.73	0.43
Total Debt / EBITDA	7.05	7.37	17.53	12.14	10.5
Net Debt / EBITDA	4.36	5.76	14.85	11.23	9.81
Total Debt / (EBITDA - Capex)	32.84	14.51	-75.55	23.05	47.76
Net Debt / (EBITDA - Capex)	20.33	11.34	-63.97	21.32	44.59
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	7.05	12.99	-1.04	7.14	11.19
Gross Profit, 1 Yr. Growth %	18.53	11.03	-13.56	2.76	10.1
EBITDA, 1 Yr. Growth %	20.1	0.29	-51.22	27.03	53.26
EBITA, 1 Yr. Growth %	21.16	-12.75	-108.29	-241.52	522.21
EBIT, 1 Yr. Growth %	21.53	-18.35	-130.74	-49.67	-418.47
Earnings From Cont. Operations, 1 Yr. Growth %	81.43	-53.86	-220	-84.52	277.11
Net Income, 1 Yr. Growth %	-67.67	-40.61	-264.93	-144.38	-389.34
Normalized Net Income, 1 Yr. Growth %	-157.03	-222.13	-174.37	-688.92	-114.1
Diluted EPS Before Extra, 1 Yr. Growth %	-10.32	-40.82	-259.75	-144.13	-389.43
Accounts Receivable, 1 Yr. Growth %	9.7	-4.58	14.15	-12.29	5.97
Inventory, 1 Yr. Growth %	3.65	-0.38	14.78	31.24	19.58
Net Property, Plant and Equip., 1 Yr. Growth %	9.99	5.4	-2.71	-7.93	10.45
Total Assets, 1 Yr. Growth %	7.89	2.72	4.05	-1.8	10.86
Tangible Book Value, 1 Yr. Growth %	-15.33	-18.59	-14.71	11.22	-38.22
Common Equity, 1 Yr. Growth %	11.54	1.2	-5.54	1.41	-9.37
Cash From Operations, 1 Yr. Growth %	190.08	-6.37	-140.82	126.83	-127.02
Capital Expenditures, 1 Yr. Growth %	7.49	-37.21	22.87	-51.21	152.66
Levered Free Cash Flow, 1 Yr. Growth %	-37.73	-101.85	-15.5K	-79.34	153.64
Unlevered Free Cash Flow, 1 Yr. Growth %	-55.85	-224.62	-712.56	-103	-1.22K
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	11.01	9.98	5.74	2.97	9.14
Gross Profit, 2 Yr. CAGR %	21.52	14.72	-2.03	-5.75	6.36
EBITDA, 2 Yr. CAGR %	9.55	9.75	-29.87	-21.28	39.53
EBITA, 2 Yr. CAGR %	13.66	2.81	-72.97	-65.74	196.74
EBIT, 2 Yr. CAGR %	13.5	-0.38	-49.62	-60.67	26.6
Earnings From Cont. Operations, 2 Yr. CAGR %	264.73	-8.51	-25.09	-56.9	-23.6
Net Income, 2 Yr. CAGR %	332.3	-56.18	-1.03	-14.45	13.32
Normalized Net Income, 2 Yr. CAGR %	-42.31	-16.54	-3.69	109.28	-8.89
Diluted EPS Before Extra, 2 Yr. CAGR %	12.96	-26.9	-1.33	-16.14	14.19
Accounts Receivable, 2 Yr. CAGR %	9.11	2.31	4.37	0.06	-3.59
Inventory, 2 Yr. CAGR %	5.7	1.62	6.93	22.73	25.27
Net Property, Plant and Equip., 2 Yr. CAGR %	-4.47	7.67	1.27	-5.36	0.84
Total Assets, 2 Yr. CAGR %	12.28	5.27	3.39	1.09	4.34
Tangible Book Value, 2 Yr. CAGR %	-12.92	-16.98	-16.67	-2.6	-17.11
Common Equity, 2 Yr. CAGR %	12.32	6.25	-2.23	-2.13	-4.13
Cash From Operations, 2 Yr. CAGR %	268.29	64.8	-38.18	-3.78	-21.72
Capital Expenditures, 2 Yr. CAGR %	-8.39	-17.85	-12.16	-22.58	11.03
Levered Free Cash Flow, 2 Yr. CAGR %	-39.13	-89.26	123.5	464.15	-27.6
Unlevered Free Cash Flow, 2 Yr. CAGR %	-53.42	-25.83	179.22	-57.11	-42.03
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	5.92	11.66	6.18	6.2	5.64
Gross Profit, 3 Yr. CAGR %	15.67	17.92	4.39	-0.46	-0.74
EBITDA, 3 Yr. CAGR %	15.4	6.37	-16.09	-14.51	-1.7
EBITA, 3 Yr. CAGR %	19.72	4.07	-55.43	-53.07	-9.95
EBIT, 3 Yr. CAGR %	20.37	1.7	-32.43	-49.63	-21.02
Earnings From Cont. Operations, 3 Yr. CAGR %	87.46	83.09	0.6	-55.71	-11.19
Net Income, 3 Yr. CAGR %	44.11	123.06	-31.84	-24.25	28.42
Normalized Net Income, 3 Yr. CAGR %	17.67	-25.93	-19.12	76.12	-14.85
Diluted EPS Before Extra, 3 Yr. CAGR %	43.47	-8.74	-4.21	-24.61	27.6
Accounts Receivable, 3 Yr. CAGR %	5.05	4.34	6.12	-1.51	1.99
Inventory, 3 Yr. CAGR %	5.52	3.64	5.83	14.49	21.67
Net Property, Plant and Equip., 3 Yr. CAGR %	1.07	-1.28	4.09	-1.9	-0.36
Total Assets, 3 Yr. CAGR %	9.98	9	4.87	1.63	4.24
Tangible Book Value, 3 Yr. CAGR %	-8.61	-14.85	-16.23	-8.25	-16.32
Common Equity, 3 Yr. CAGR %	8.43	8.48	2.16	-1.03	-4.6
Cash From Operations, 3 Yr. CAGR %	40.21	133.31	3.49	-4.65	-36.99
Capital Expenditures, 3 Yr. CAGR %	-0.4	-19.23	-6.05	-27.8	14.84
Levered Free Cash Flow, 3 Yr. CAGR %	-22.75	-81	45.98	1.06	332.19
Unlevered Free Cash Flow, 3 Yr. CAGR %	-34.56	-35.33	50.99	-38.37	27.22
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	6.33	7.25	5.85	8.1	7.35
Gross Profit, 5 Yr. CAGR %	9.88	11.12	8.24	7.81	5.18
EBITDA, 5 Yr. CAGR %	2.01	-0.57	-5.44	-5.59	2.84
EBITA, 5 Yr. CAGR %	-1.74	-6.66	-33.99	-33.14	-4.86
EBIT, 5 Yr. CAGR %	-2.83	-8.9	-15.04	-30.29	-13.14
Earnings From Cont. Operations, 5 Yr. CAGR %	11.44	-3.59	29.89	2.93	-9.88
Net Income, 5 Yr. CAGR %	3.22	-5.42	24	52.04	-16.47
Normalized Net Income, 5 Yr. CAGR %	-9.14	-2.32	8.61	12.7	-15.18
Diluted EPS Before Extra, 5 Yr. CAGR %	2.94	-5.61	23.68	-11.25	2.71
Accounts Receivable, 5 Yr. CAGR %	6.07	3.82	4.78	2.61	2.12
Inventory, 5 Yr. CAGR %	0.77	0.34	6.08	10.89	13.21
Net Property, Plant and Equip., 5 Yr. CAGR %	5.03	3.01	1.15	-2.93	2.78
Total Assets, 5 Yr. CAGR %	9.23	7	7.29	5.76	4.66
Tangible Book Value, 5 Yr. CAGR %	-4.64	-9.29	-11.92	-10.15	-16.58
Common Equity, 5 Yr. CAGR %	5.85	5.01	4.03	4.11	-0.4
Cash From Operations, 5 Yr. CAGR %	164.24	-7.63	1.05	63.7	-7.44
Capital Expenditures, 5 Yr. CAGR %	-6.12	-17.9	-5.28	-20.58	0.44
Levered Free Cash Flow, 5 Yr. CAGR %	-27.61	-59.23	18.16	-17.49	10.27
Unlevered Free Cash Flow, 5 Yr. CAGR %	-35.92	-14.26	16.92	-44.9	2.96